drivers in HTAs today (scale 1, low to 5, high) were clinical trial design (mean 4.45), right endpoints (mean 4.40), and size …‑relevant endpoints; and a transparent and consistent management of both HTA and regulatory procedures as well as their interface …

towards the choice of adequate comparator(s), selection of endpoints that are relevant to patients with a given disease … and endpoint selection, were identifed. At the inaugural convention of the European Access Academy dedicated working … fragmented treatment landscape, ii) reasonable number of comparators in PICOs, iii) shape Early Advice so that comparator fulfls …

towards the choice of adequate comparator(s), selection of endpoints that are relevant to patients with a given disease … and endpoint selection, were identifed. At the inaugural convention of the European Access Academy dedicated working … fragmented treatment landscape, ii) reasonable number of comparators in PICOs, iii) shape Early Advice so that comparator fulfls …

unveiled issues regarding the acceptance of some patient-relevant endpoints as G-BA and IQWiG are grading the endpoints … endpoints including survival of patients without their disease getting worse (i.e., progression-free survival). Also … clinical trial programs that were developed to be consistent with regulatory guidance, endpoints in oncology are thoroughly …

unveiled issues regarding the acceptance of some patient-relevant endpoints as G-BA and IQWiG are grading the endpoints … endpoints including survival of patients without their disease getting worse (i.e., progression-free survival). Also … clinical trial programs that were developed to be consistent with regulatory guidance, endpoints in oncology are thoroughly …

This paper is a study on Access, Participation, and Performance of Girls in Science and Technology in Nepal. This study …, identify stakeholders’ perspective towards girls’ access to and participation in Science and Technology Education (STE …